Novavax, Inc.

“Pipeline in a pill”-style drug development will be on display in April, when more than half of the user fee goal dates are for new indications on sometimes sprawling labels, as well as one novel biol

A partnership with French drug maker Sanofi, leveraging its platform and pipeline to find new partnerships, and advancing the pipeline form the three main strategic priorities for Novavax as it works

In Vivo ’s editors, along with experts from the Citeline team, selected four top picks for the most significant M&A, alliance and financing deals of 2022. The public votes have been counted and it

A US Food and Drug Administration advisory committee discussion of pediatric respiratory syncytial virus vaccine safety concerns underscores the communication challenges the agency faces in an era of